Black Seed Oil for Cholesterol: What the Research Actually Shows
Black seed oil for cholesterol is one of the more heavily studied questions about Nigella sativa, and one of the most casually reported. Pooled analyses of randomised trials do describe reductions in total cholesterol, LDL cholesterol and triglycerides. What they do not describe — because it has never been measured — is whether anybody taking black seed oil went on to have fewer heart attacks or strokes. This article is about that distinction, and about how certain the underlying evidence actually is.
What follows covers the meta-analyses, the key trials, the mechanisms proposed, the formal certainty ratings, and how any of this sits alongside medical management of cholesterol. For broader context, see our research-backed benefits guide, our article on black seed oil and heart health, and our inflammation guide.
On quality specifically: Sidr & Stone’s black seed oil is independently verified at 2.67% thymoquinone by Analytice, an ISO-accredited French laboratory, on a per-batch basis. That is a statement about what is in a bottle, not a claim about what it will do to a blood test.
The Short Answer
- Meta-analyses of randomised trials report reductions in total cholesterol, LDL cholesterol and triglycerides versus placebo, with inconsistent effects on HDL. These are pooled averages of short trials, not a promise about any individual.
- The largest synthesis is Jafari A and colleagues, Pharmacological Research 2025;219:107882 (PMID 40714301): 82 randomised trials, 5,026 participants, 200–4,600 mg/day, 1–48 weeks. Its own title asks whether N. sativa improves cardiovascular disease risk factors — which is what it measured.
- A cholesterol number is a surrogate marker. No trial of black seed oil has ever reported a heart attack, a stroke, a hospital admission or a death. The evidence base on hard cardiovascular endpoints is empty.
- Certainty is low. An umbrella review of 20 meta-analyses graded 88 of 110 outcome indicators very low and rated 15 of the 20 reviews critically low on methodological quality.
- Where pooled results are null, they are null: across 50 randomised trials, C-reactive protein, TNF-α, total antioxidant capacity and malondialdehyde all came back non-significant.
- Nobody should stop, reduce or alter a prescribed cholesterol medicine because of anything on this page. That is a decision for your doctor.
Understanding Cholesterol Briefly
Cholesterol is a waxy substance essential for cell membranes, hormone production, and vitamin D synthesis. The cholesterol tests most people have include:
- Total cholesterol: Overall cholesterol level
- LDL (low-density lipoprotein): Often called "bad" cholesterol — elevated levels are associated with atherosclerosis
- HDL (high-density lipoprotein): Often called "good" cholesterol — involved in removing cholesterol from arteries
- Triglycerides: Fat carried in blood — elevated levels are associated with cardiovascular risk
- Non-HDL cholesterol: Total cholesterol minus HDL, often considered a better risk indicator
Cardiovascular risk is influenced by multiple factors beyond cholesterol numbers alone — blood pressure, inflammation, insulin resistance, smoking, family history, and lifestyle factors all contribute. Cholesterol is one piece of the picture, not the whole picture.
What the Meta-Analyses Show
Sahebkar 2016 — foundational lipid meta-analysis
A systematic review and meta-analysis of 17 randomised placebo-controlled trials examining Nigella sativa's effects on plasma lipid concentrations in humans reported statistically significant reductions in:
- Total cholesterol
- LDL cholesterol
- Triglycerides
Effects on HDL were less consistent across trials, with some showing modest increases and others showing no significant change.
2025 Jafari dose-response meta-analysis
The most comprehensive synthesis to date pooled 82 randomised controlled trials involving 5,026 participants, published between 2008 and 2024, with interventions running from 1 to 48 weeks and doses from 200 to 4,600 mg/day. It reported improvements in a long list of measurements, including:
- Total cholesterol
- LDL cholesterol
- Triglycerides
- HDL cholesterol (modest)
- Total cholesterol to HDL ratio
- Blood pressure, fasting glucose and HbA1c
It is a striking list, and it is worth naming exactly what kind of list it is. Every item on it is a risk factor — something measured from a blood sample or a cuff. The authors' own conclusion is that N. sativa "could be a promising adjunct therapy for improving cardiovascular disease risk factors". Not events. Not outcomes. Risk factors.
How certain is any of this? The GRADE answer
There is a formal system for answering that question, and it has been applied here. Li Z, Wang Y, Xu Q, Ma J, Li X, Yan J, Tian Y, Wen Y and Chen T published an overview of systematic reviews in Frontiers in Nutrition in 2023, assessing 20 meta-analyses of N. sativa using AMSTAR-2 for methodological quality and GRADE for certainty of evidence.
Of the 20 reviews, one was rated moderate quality, four low, and fifteen critically low. Across 110 outcome indicators, five were graded moderate certainty, 17 low, and 88 very low. Risk of bias, inconsistency and imprecision were the main reasons for downgrading. The authors concluded that clinical efficacy "requires confirmation in high-quality, large-sample, randomized controlled trials".
It is also worth being straight about where the pooled results are simply null. Hallajzadeh J and colleagues, in Phytotherapy Research in 2020, pooled 50 randomised trials and found no significant effect on C-reactive protein, TNF-α, total antioxidant capacity or malondialdehyde — four of the inflammatory and oxidative markers most often invoked in cardiovascular marketing. The same analysis did find significant reductions in total cholesterol, triglycerides, LDL and VLDL.
What the numbers look like — with the caveats attached
Individual trials have reported reductions in the range of 8–20% for total cholesterol, 10–25% for LDL, and 10–30% for triglycerides, with HDL changes between none and about 10%. Those ranges are wide for a reason: the trials differ in population, preparation, dose and duration, heterogeneity between them is high, and the certainty attached to most of these outcomes is very low. Read them as a description of a scattered literature, not as a forecast for your next blood test.
Key Individual Trials
Shoaei-Hagh 2021 — adults with hypertension
A randomised double-blind placebo-controlled trial in adults with hypertension ran for eight weeks. Beyond its primary blood pressure outcomes, it reported improvements in:
- Total cholesterol
- LDL cholesterol
- Triglycerides
- HDL cholesterol
- Fasting blood sugar
- Oxidative stress markers
This trial is often cited because several measurements moved at once. It remains a single eight-week trial reporting laboratory measurements.
Ibrahim 2014 — menopausal women
A randomised controlled trial examining hypolipidemic effects of Nigella sativa seed powder in menopausal women, published in the Journal of Translational Medicine, reported improvements in total cholesterol, LDL cholesterol and triglycerides. Note the preparation: seed powder, not oil. That distinction gets lost in most summaries of this literature.
Mahdavi 2015 — obese women
Combining Nigella sativa oil with a low-calorie diet over 8 weeks produced greater reductions in triglycerides and VLDL, alongside greater weight loss, than the diet alone — which suggests any effect here sits on top of dietary change rather than replacing it.
How Black Seed Oil May Affect Lipids
Several mechanisms have been proposed. All of them are accounts of how the measurements might have moved, not evidence that the movement matters:
HMG-CoA reductase influence
HMG-CoA reductase is the enzyme that controls cholesterol synthesis in the liver. Research suggests thymoquinone may moderately influence this enzyme's activity in laboratory models.
LDL receptor activity
Some research indicates black seed oil may influence LDL receptor expression in the liver, which would affect clearance of LDL from the bloodstream.
Antioxidant protection
Oxidised LDL is more atherogenic than unoxidised LDL, and thymoquinone is described in the literature as an antioxidant. Whether that translates into anything measurable in people has not been tested.
Anti-inflammatory effects
Chronic inflammation is independently associated with atherogenesis. As noted above, though, the pooled human data on CRP and TNF-α for Nigella sativa are null. See our inflammation guide.
Bile acid metabolism
Some research suggests effects on bile acid metabolism, potentially influencing cholesterol conversion and excretion.
Essential fatty acids
Black seed oil contains significant polyunsaturated and monounsaturated fatty acids, including linoleic acid (omega-6) and oleic acid (omega-9), which have documented roles in lipid metabolism.
What a Change in a Cholesterol Number Does and Does Not Tell You
This is the part of the topic that most articles skip, and it matters more than any percentage.
A lipid number is a surrogate marker, not an event
In cardiovascular medicine there are two kinds of outcome. Surrogate markers are measurements taken from a blood sample or a cuff — LDL, triglycerides, C-reactive protein. Hard endpoints are things that happen to people: myocardial infarction, stroke, cardiovascular death. Surrogates are cheap and fast to measure. Endpoints are what medicine actually cares about, and the two do not always move together.
The entire Nigella sativa lipid literature sits on the surrogate side of that line. Not because researchers were careless, but because event trials need thousands of participants followed for years and nobody has funded one. The reason there is no evidence about heart attacks is that the question has never been asked.
Medication is a decision for your doctor, not for us
We are not going to set this oil against any prescribed medicine, favourably or unfavourably — there is no comparison to make, because black seed oil has never been tested against the outcomes that prescribed cholesterol medicines are prescribed to change. What we will say plainly: nobody should start, stop, reduce or alter a prescribed medicine on the basis of an article, and any decision about cholesterol medication belongs to you and your GP or cardiologist.
Where a food can reasonably sit
Diet, physical activity, weight, smoking and alcohol are the levers with the strongest evidence behind them for anyone working on their lipids without medication. Black seed oil is a food; if you want it in your routine as one, it sits alongside those things rather than in place of them. If your cholesterol is high enough to worry a clinician, that is a conversation to have with the clinician.
When self-management is not appropriate at all
- Familial hypercholesterolaemia (genetic severe elevation)
- Previous cardiovascular events
- Very high baseline LDL
- Any situation where your doctor has prescribed treatment
Using Black Seed Oil as a Food
We do not publish a dose for cholesterol
A dose attached to a named condition is a medicine claim, and black seed oil is a food supplement, not a medicine. So there is no protocol here. As a food, a common culinary serving is 1–2 teaspoons (5–10ml) of cold-pressed oil a day, taken with food containing some fat. That is a serving, not a treatment.
Why a trial dose cannot be read off a retail bottle
Even if you wanted to copy a trial, you could not do it reliably. A 2022 analysis found thymoquinone ranging from 3.08 to 809.4 mg per 100 g across eleven commercial Nigella sativa products — a more-than-250-fold difference. Two teaspoons of "black seed oil" can therefore differ by more than two orders of magnitude in the compound the research is about, which makes any millilitre figure close to meaningless without a verified thymoquinone number attached to it.
What the trials themselves ran for
For reference rather than instruction: the trials reporting lipid changes generally ran eight weeks or longer, and lipid panels in research settings are typically repeated at twelve weeks. Those are study durations. If you want your own lipids monitored, ask your GP — that is what a lipid panel is for.
What actually has strong evidence
- Mediterranean or similar evidence-based dietary pattern
- Reduced saturated and trans fat intake
- Increased soluble fibre (oats, beans, apples, pears)
- Regular physical activity (particularly cardiovascular exercise)
- Weight management where appropriate
- Smoking cessation if applicable
- Moderation of alcohol
Honest Expectations
- What was measured: pooled reductions in LDL and triglycerides across short trials, typically in the 10–20% range, with wide variation between studies
- How certain it is: very low for most outcomes, on the formal GRADE assessment of this literature
- What was never measured: a heart attack, a stroke, a hospital admission or a death — in any trial, ever
- Individual variation: response in trials depended on baseline levels, diet, genetics, preparation and duration
- Monitoring: total cholesterol alone is insufficient; LDL, HDL, triglycerides and ratios all matter, and reading them is a clinician's job
If you are expecting dramatic lipid normalisation from a supplement alone, no evidence supports that — including for black seed oil. If you want a food with an interesting research literature attached to it, that is what this is.
Important: If You Are on Prescribed Medication
Do not stop or reduce prescribed cholesterol medication in order to take black seed oil. Prescribed cholesterol medicines are chosen on the basis of trials that counted cardiovascular events, and discontinuing them without medical guidance can materially increase risk in people who need them.
If you want to add black seed oil alongside prescribed treatment:
- Discuss it with your GP, pharmacist or cardiologist first
- Tell them about every supplement you take, not just this one
- Combined effects have not been systematically characterised
- Continue lipid monitoring exactly as your doctor directs
If your doctor has raised the possibility of reducing medication through lifestyle change, that is a conversation to have with them, with monitoring — not a decision to make after reading a supplement page.
Safety Considerations
- Pregnancy: Do not take supplemental doses during pregnancy
- Nursing: Limited safety data — consult your GP
- Blood thinners: Thymoquinone has anticoagulant effects — particularly relevant for those on warfarin, aspirin, or similar. Consult your GP or anticoagulant clinic
- Blood pressure medication: Additive blood-pressure-lowering effects are plausible
- Diabetes medication: Additive glucose-lowering effects are plausible
- Any prescribed cholesterol medicine: Discuss combined use with your prescribing doctor
- Liver conditions: Discuss with your healthcare provider
- Surgery: Declare every supplement you take and discontinue 2 weeks before any scheduled procedure
For the complete safety picture, see our side effects and safety guide.
Why Quality Matters
The clinical trials in this area used characterised Nigella sativa with a known thymoquinone content. The 3.08 to 809.4 mg per 100 g spread found across commercial products is the one part of this topic where the evidence is unambiguous — and it is a quality problem rather than a cholesterol problem. An oil at 0.5% thymoquinone cannot deliver what an oil at 2%+ delivers at the same volume.
Our cold-pressed Ethiopian black seed oil is independently tested at 2.67% thymoquinone — selected after evaluating 36 suppliers — and you can view the certificate. See our thymoquinone guide for full context on why concentration matters. Knowing what is in the bottle is worth something on its own; it is not an argument that the bottle will change your blood test.
Frequently Asked Questions
Does black seed oil actually lower cholesterol?
Meta-analyses of randomised trials report reductions in total cholesterol, LDL cholesterol and triglycerides versus placebo. That is a description of pooled short-term data, not a claim about what will happen to you — and when the GRADE framework was applied across this literature, 88 of 110 outcome indicators came back very low certainty. Black seed oil is a food supplement, not a cholesterol treatment.
How much does black seed oil lower cholesterol in trials?
Reported ranges are roughly 8–20% for total cholesterol and 10–25% for LDL, varying widely by population, preparation, dose and duration. Heterogeneity between the trials is high and the certainty attached to most of these outcomes is very low, so the pooled average conceals more than it reveals.
Has any trial shown black seed oil prevents heart attacks or strokes?
No. Not one trial of Nigella sativa has reported myocardial infarction, stroke, hospital admission or cardiovascular death as an outcome. A lipid number is a surrogate marker; the evidence base on hard cardiovascular endpoints is empty.
Can I take black seed oil instead of my prescribed cholesterol medicine?
No, and nobody should attempt it. Prescribed cholesterol medicines are chosen on the basis of trials that counted events, which black seed oil has never been tested against. Never stop or reduce a prescribed medicine without your doctor's direction — if you want to discuss alternatives, that conversation belongs with your GP or cardiologist.
Can I take black seed oil alongside prescribed medication?
That is a question for your prescriber. No specific harmful interaction with cholesterol medicines has been documented, but combined use has not been systematically studied, and your doctor will want to know about every supplement you take.
Does black seed oil raise HDL ("good") cholesterol?
Effects on HDL are less consistent than effects on LDL and triglycerides. Some trials report modest increases; others report no significant change. The 2025 pooled analysis reported a modest overall HDL improvement across the trials it included.
What about triglycerides specifically?
Triglyceride reductions are typically the most pronounced lipid change reported — often in the 10–30% range across trials. The same caveats apply: short trials, high heterogeneity, low certainty, and no measured clinical outcome.
Is black seed oil a medicine?
No. Black seed oil is a food supplement, not a medicine. It has a long traditional history and an interesting body of research around thymoquinone, and can be a worthwhile part of a healthy routine — but it does not cure diseases and is not a substitute for medical care. Be cautious of any black seed oil marketed with specific disease-cure claims.
Final Thoughts
Three things are true at once here, and most articles on this topic only tell you the first. Pooled analyses of randomised trials do report reductions in total cholesterol, LDL and triglycerides. The formal certainty attached to those findings is very low, with 88 of 110 outcome indicators graded very low and fifteen of twenty reviews rated critically low on methodology. And no trial has measured whether any of it makes a difference to a person's life — a lipid number is a surrogate, and the event trials do not exist.
Eighty-two trials sounds like a lot. Quantity of evidence and certainty of evidence are different things, and GRADE exists to keep them apart. Anyone reading this who has been told their cholesterol is a problem should be having that conversation with a clinician, not with a supplement page — and nobody should alter or stop prescribed medication on the strength of an article.
What we can honestly offer is a food whose contents are measured rather than asserted. Our cold-pressed Ethiopian black seed oil is independently tested at 2.67% thymoquinone — sourced from Ethiopian highland seeds after evaluating 36 suppliers, cold-pressed below 40°C, and packaged in matte black UV-protective glass.
Shop Sidr & Stone Cold-Pressed Ethiopian Black Seed Oil — Verified 2.67% Thymoquinone →
References
1. Sahebkar A, Beccuti G, Simental-Mendía LE, Nobili V, Bo S. (2016). Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacological Research, 106, 37–50. View study.
2. Jafari A, Mardani H, Faghfouri AH, Fashtali ZM, Hashemi M, Yousefabady MA, Javid R, Golabi S, Arghavan B, Musazadeh V, Naghashpour M. (2025). Does Nigella sativa supplementation improve cardiovascular disease risk factors? A comprehensive GRADE-assessed systematic review and dose-response meta-analysis of 82 randomized controlled trials. Pharmacological Research, 219, 107882. PMID: 40714301. doi:10.1016/j.phrs.2025.107882. View study.
3. Li Z, Wang Y, Xu Q, Ma J, Li X, Yan J, Tian Y, Wen Y, Chen T. (2023). Nigella sativa and health outcomes: an overview of systematic reviews and meta-analyses. Frontiers in Nutrition, 10, 1107750. PMID: 37057067. doi:10.3389/fnut.2023.1107750.
4. Hallajzadeh J, Milajerdi A, Mobini M, Amirani E, Azizi S, Nikkhah E, Bahadori B, Sheikhsoleimani R, Mirhashemi SM. (2020). Effects of Nigella sativa on glycemic control, lipid profiles, and biomarkers of inflammatory and oxidative stress: a systematic review and meta-analysis of randomized controlled clinical trials. Phytotherapy Research, 34(10), 2586–2608. PMID: 32394508. doi:10.1002/ptr.6708.
5. Shoaei-Hagh P, Kamelan Kafi F, Najafi S, et al. (2021). A randomized, double-blind, placebo-controlled, clinical trial to evaluate the benefits of Nigella sativa seeds oil in reducing cardiovascular risks in hypertensive patients. Phytotherapy Research, 35(8), 4388–4400.
6. Ibrahim RM, Hamdan NS, Mahmud R, et al. (2014). A randomised controlled trial on hypolipidemic effects of Nigella sativa seeds powder in menopausal women. Journal of Translational Medicine, 12, 82.
7. Mahdavi R, Namazi N, Alizadeh M, Farajnia S. (2015). Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial. Food & Function, 6(6), 2041–2048.
8. Hannan MA, Rahman MA, Sohag AAM, et al. (2021). Black cumin (Nigella sativa L.): A comprehensive review on phytochemistry, health benefits, molecular pharmacology, and safety. Nutrients, 13(6), 1784.
Disclaimer: This article describes what published research on black seed oil and blood lipid markers has and has not measured at the time of writing; research findings and product specifications may change, and readers should check current sources. It is not a recommendation to use black seed oil for high cholesterol, cardiovascular disease or any related condition. Black seed oil is a food supplement, not a medicine, and is not a substitute for medical treatment of any condition. Never stop, reduce or alter prescribed medication without your doctor's direction. For any health concern, consult a qualified medical professional.